Skip to main content
Premium Trial:

Request an Annual Quote

The Mint Julep Will Have to Wait


When the time came for Stephen Hoffman to retire, rocking chairs and golf clubs weren’t in the picture. The 52-year-old former leader of malaria research efforts and vaccine development for the US Navy served for 21 years, long enough to retire with full benefits, according to Navy policy. Rather than find a condo in Florida, Hoffman joined Celera in the new position of senior vice president of immunotherapies.

Celera has professed an interest in moving toward drug discovery since early last year, and Hoffman sees his appointment as “the beginning of the actualization of [that] direction.” His mission is to enable Celera to capitalize on its genomics experience and information database. His tasks will include helping to characterize proteomes as well as developing new therapeutics, preventatives, and diagnostics.

Hoffman says cancer will be the first focus. “We’ll be developing therapeutic monoclonal antibodies,” but he will also work on vaccination strategies. “We’ll be very happy in the next few years if we can develop a series of new products based on our discovery technology.”

Asked whether he has found any differences between working for the Navy and for Celera, Hoffman says, “Not yet.”

— Meredith Salisbury

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.